

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * viral transcription (GO:0019083) | 8.25460969 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 8.14387474 |
| 3 | * translational termination (GO:0006415) | 7.95861983 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 7.31117603 |
| 5 | * translational elongation (GO:0006414) | 6.93059015 |
| 6 | maturation of SSU-rRNA (GO:0030490) | 6.83781632 |
| 7 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.81879228 |
| 8 | * cotranslational protein targeting to membrane (GO:0006613) | 6.68650536 |
| 9 | * protein targeting to ER (GO:0045047) | 6.67685235 |
| 10 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.38073509 |
| 11 | * nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 6.34950444 |
| 12 | * protein localization to endoplasmic reticulum (GO:0070972) | 6.24010726 |
| 13 | * viral life cycle (GO:0019058) | 6.23349782 |
| 14 | * cellular protein complex disassembly (GO:0043624) | 6.19974957 |
| 15 | * translational initiation (GO:0006413) | 6.14665380 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 5.62127065 |
| 17 | * protein complex disassembly (GO:0043241) | 5.47638247 |
| 18 | * macromolecular complex disassembly (GO:0032984) | 5.12394172 |
| 19 | formation of translation preinitiation complex (GO:0001731) | 4.86133425 |
| 20 | * nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.63854329 |
| 21 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.56776995 |
| 22 | * translation (GO:0006412) | 4.50707241 |
| 23 | * protein targeting to membrane (GO:0006612) | 4.44283982 |
| 24 | * mRNA catabolic process (GO:0006402) | 4.39555544 |
| 25 | * RNA catabolic process (GO:0006401) | 4.15289504 |
| 26 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.88443563 |
| 27 | DNA unwinding involved in DNA replication (GO:0006268) | 3.79285916 |
| 28 | rRNA processing (GO:0006364) | 3.76600661 |
| 29 | DNA strand elongation (GO:0022616) | 3.68163849 |
| 30 | rRNA metabolic process (GO:0016072) | 3.61954575 |
| 31 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.61385995 |
| 32 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.52771743 |
| 33 | establishment of integrated proviral latency (GO:0075713) | 3.50596863 |
| 34 | DNA deamination (GO:0045006) | 3.50121778 |
| 35 | DNA replication initiation (GO:0006270) | 3.43483548 |
| 36 | cellular component biogenesis (GO:0044085) | 3.38061045 |
| 37 | regulation of mitochondrial translation (GO:0070129) | 3.29720667 |
| 38 | ribosome biogenesis (GO:0042254) | 3.18435190 |
| 39 | transcription from mitochondrial promoter (GO:0006390) | 3.17646152 |
| 40 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.15823491 |
| 41 | nucleobase biosynthetic process (GO:0046112) | 3.14933315 |
| 42 | telomere maintenance via recombination (GO:0000722) | 3.13656920 |
| 43 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.12927350 |
| 44 | ribosome assembly (GO:0042255) | 3.11042022 |
| 45 | spliceosomal snRNP assembly (GO:0000387) | 3.08505361 |
| 46 | chaperone-mediated protein transport (GO:0072321) | 3.07688877 |
| 47 | * establishment of protein localization to membrane (GO:0090150) | 3.04744025 |
| 48 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.03458205 |
| 49 | protein localization to kinetochore (GO:0034501) | 2.98870165 |
| 50 | mitotic recombination (GO:0006312) | 2.98174769 |
| 51 | mitotic chromosome condensation (GO:0007076) | 2.95367519 |
| 52 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.95076737 |
| 53 | negative regulation of ligase activity (GO:0051352) | 2.95076737 |
| 54 | respiratory electron transport chain (GO:0022904) | 2.95075031 |
| 55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.94738048 |
| 56 | * protein localization to membrane (GO:0072657) | 2.92414299 |
| 57 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.91590547 |
| 58 | regulation of translational fidelity (GO:0006450) | 2.90547301 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.90437293 |
| 60 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.90307759 |
| 61 | telomere maintenance via telomere lengthening (GO:0010833) | 2.89848623 |
| 62 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.89708471 |
| 63 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.89131875 |
| 64 | negative regulation of RNA splicing (GO:0033119) | 2.88881884 |
| 65 | electron transport chain (GO:0022900) | 2.87438197 |
| 66 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.86193743 |
| 67 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.86193743 |
| 68 | * establishment of protein localization to organelle (GO:0072594) | 2.86037938 |
| 69 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.85520676 |
| 70 | pseudouridine synthesis (GO:0001522) | 2.84467294 |
| 71 | IMP biosynthetic process (GO:0006188) | 2.82962932 |
| 72 | ncRNA 3-end processing (GO:0043628) | 2.82704851 |
| 73 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.82294427 |
| 74 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.82294427 |
| 75 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.82294427 |
| 76 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.81991098 |
| 77 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.81991098 |
| 78 | mitotic nuclear envelope disassembly (GO:0007077) | 2.81907864 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81122731 |
| 80 | * protein targeting (GO:0006605) | 2.79830485 |
| 81 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.78849891 |
| 82 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.78849891 |
| 83 | spliceosomal complex assembly (GO:0000245) | 2.78782716 |
| 84 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.78687612 |
| 85 | establishment of viral latency (GO:0019043) | 2.78579385 |
| 86 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.76414904 |
| 87 | purine nucleobase biosynthetic process (GO:0009113) | 2.76408548 |
| 88 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.75128525 |
| 89 | DNA replication checkpoint (GO:0000076) | 2.74732130 |
| 90 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.74301182 |
| 91 | termination of RNA polymerase III transcription (GO:0006386) | 2.74301182 |
| 92 | proteasome assembly (GO:0043248) | 2.72677387 |
| 93 | CENP-A containing nucleosome assembly (GO:0034080) | 2.72008999 |
| 94 | chromatin remodeling at centromere (GO:0031055) | 2.67603296 |
| 95 | protein targeting to mitochondrion (GO:0006626) | 2.67515444 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.67354349 |
| 97 | rRNA modification (GO:0000154) | 2.67114523 |
| 98 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.66960868 |
| 99 | ATP synthesis coupled proton transport (GO:0015986) | 2.66960868 |
| 100 | ncRNA processing (GO:0034470) | 2.66407005 |
| 101 | regulation of protein heterodimerization activity (GO:0043497) | 2.63051797 |
| 102 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.62222544 |
| 103 | mRNA splicing, via spliceosome (GO:0000398) | 2.62222544 |
| 104 | RNA splicing, via transesterification reactions (GO:0000375) | 2.61915905 |
| 105 | * gene expression (GO:0010467) | 2.60105228 |
| 106 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.58958580 |
| 107 | membrane disassembly (GO:0030397) | 2.58011652 |
| 108 | nuclear envelope disassembly (GO:0051081) | 2.58011652 |
| 109 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.57008660 |
| 110 | DNA replication-independent nucleosome organization (GO:0034724) | 2.57008660 |
| 111 | ribonucleoprotein complex assembly (GO:0022618) | 2.56696513 |
| 112 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.56525030 |
| 113 | cell cycle G1/S phase transition (GO:0044843) | 2.56525030 |
| 114 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.56511828 |
| 115 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.55549137 |
| 116 | ribonucleoprotein complex subunit organization (GO:0071826) | 2.55318322 |
| 117 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.53357354 |
| 118 | * protein localization to organelle (GO:0033365) | 2.48638989 |
| 119 | nuclear pore complex assembly (GO:0051292) | 2.46582789 |
| 120 | oxidative phosphorylation (GO:0006119) | 2.45571345 |
| 121 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.43074223 |
| 122 | ncRNA metabolic process (GO:0034660) | 2.42133762 |
| 123 | establishment of protein localization to mitochondrion (GO:0072655) | 2.39206343 |
| 124 | * cellular component disassembly (GO:0022411) | 2.38916953 |
| 125 | pentose metabolic process (GO:0019321) | 2.35557543 |
| 126 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.34887789 |
| 127 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.34759641 |
| 128 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.34068845 |
| 129 | mitochondrial RNA metabolic process (GO:0000959) | 2.33656925 |
| 130 | GDP-mannose metabolic process (GO:0019673) | 2.31873409 |
| 131 | positive regulation of viral transcription (GO:0050434) | 2.29364686 |
| 132 | inner mitochondrial membrane organization (GO:0007007) | 2.29043153 |
| 133 | myeloid cell homeostasis (GO:0002262) | 2.28094406 |
| 134 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.28031596 |
| 135 | protein localization to mitochondrion (GO:0070585) | 2.27390922 |
| 136 | regulation of translational initiation (GO:0006446) | 2.26734914 |
| 137 | mitotic sister chromatid segregation (GO:0000070) | 2.26658177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.42729765 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.54186902 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.03065543 |
| 4 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.32862617 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.17757625 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.13394965 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.12938499 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95571382 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.83719558 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.83340752 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.80970831 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.80568796 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.78542927 |
| 14 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.65585349 |
| 15 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.61208888 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.60472097 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.59560575 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.50046619 |
| 19 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.40984426 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32250963 |
| 21 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.30146495 |
| 22 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.26405648 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.06828971 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.06096846 |
| 25 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.02675557 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01984693 |
| 27 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98666751 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.98069311 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.96741928 |
| 30 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94288149 |
| 31 | * MYC_22102868_ChIP-Seq_BL_Human | 1.84806267 |
| 32 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.82699443 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80948686 |
| 34 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.76758022 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.76702670 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74208735 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70005284 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67013796 |
| 39 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66852798 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61443296 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54115773 |
| 42 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.53563354 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52057618 |
| 44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.50544977 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.49552321 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49120156 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48065463 |
| 48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47449460 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45064027 |
| 50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43369704 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.42498787 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42002975 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41278289 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41088356 |
| 55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39201740 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38096150 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31700686 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31673618 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30855855 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.30530942 |
| 61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29232072 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.28913042 |
| 63 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28521868 |
| 64 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27752241 |
| 65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25828085 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23879807 |
| 67 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.23170378 |
| 68 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21896417 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20011156 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17479081 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16914931 |
| 72 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16234767 |
| 73 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.15306743 |
| 74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14943408 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14822573 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13080257 |
| 77 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.12663732 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10416898 |
| 79 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09283404 |
| 80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08835786 |
| 81 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08404620 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07762789 |
| 83 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07473645 |
| 84 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07109997 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06697541 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06141483 |
| 87 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04568549 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.03560020 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03080728 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02815603 |
| 91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00310966 |
| 92 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00256465 |
| 93 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.00218384 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95866196 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95480697 |
| 96 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95289518 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94823842 |
| 98 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94429591 |
| 99 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93734382 |
| 100 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93067718 |
| 101 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92967422 |
| 102 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92383710 |
| 103 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92356093 |
| 104 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.90863521 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90336472 |
| 106 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88907291 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88630710 |
| 108 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.88553573 |
| 109 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86695373 |
| 110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86496875 |
| 111 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.85779999 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85718623 |
| 113 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85514935 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84892312 |
| 115 | MAF_26560356_Chip-Seq_TH1_Human | 0.84592587 |
| 116 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.84427881 |
| 117 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84172747 |
| 118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84009713 |
| 119 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.83421926 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.83320363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.72426669 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.01341249 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.42885087 |
| 4 | MP0003077_abnormal_cell_cycle | 3.33721580 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.30777066 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.22997969 |
| 7 | MP0008057_abnormal_DNA_replication | 2.82194719 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.42465950 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.37976613 |
| 10 | MP0008058_abnormal_DNA_repair | 2.36306360 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.35048046 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.11983196 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.03409130 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 1.98989766 |
| 15 | MP0001730_embryonic_growth_arrest | 1.96398188 |
| 16 | MP0000490_abnormal_crypts_of | 1.96247465 |
| 17 | MP0003123_paternal_imprinting | 1.89183238 |
| 18 | MP0000350_abnormal_cell_proliferation | 1.87753178 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 1.82286624 |
| 20 | MP0003786_premature_aging | 1.80222319 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 1.77980907 |
| 22 | MP0006054_spinal_hemorrhage | 1.65564656 |
| 23 | MP0002398_abnormal_bone_marrow | 1.56990107 |
| 24 | MP0000685_abnormal_immune_system | 1.56168930 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.56160666 |
| 26 | MP0005451_abnormal_body_composition | 1.50960210 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.48902477 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.48684668 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.47251104 |
| 30 | MP0001881_abnormal_mammary_gland | 1.46296428 |
| 31 | MP0002722_abnormal_immune_system | 1.45771718 |
| 32 | MP0002019_abnormal_tumor_incidence | 1.45412961 |
| 33 | MP0001697_abnormal_embryo_size | 1.38124323 |
| 34 | MP0010307_abnormal_tumor_latency | 1.37143468 |
| 35 | MP0002080_prenatal_lethality | 1.36967905 |
| 36 | MP0000313_abnormal_cell_death | 1.35471172 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.34684534 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.33369142 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.33369142 |
| 40 | MP0001800_abnormal_humoral_immune | 1.32605191 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.32271821 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.30844758 |
| 43 | MP0000858_altered_metastatic_potential | 1.24738112 |
| 44 | MP0002429_abnormal_blood_cell | 1.24493509 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.23980329 |
| 46 | MP0005671_abnormal_response_to | 1.23788409 |
| 47 | MP0005380_embryogenesis_phenotype | 1.22354392 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.22354392 |
| 49 | MP0000716_abnormal_immune_system | 1.20472717 |
| 50 | MP0001853_heart_inflammation | 1.19689964 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.19565936 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.19223173 |
| 53 | MP0001819_abnormal_immune_cell | 1.17271652 |
| 54 | MP0006292_abnormal_olfactory_placode | 1.16528242 |
| 55 | MP0004197_abnormal_fetal_growth/weight/ | 1.16010385 |
| 56 | MP0002084_abnormal_developmental_patter | 1.15120974 |
| 57 | MP0002085_abnormal_embryonic_tissue | 1.14685631 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.14503070 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.12901717 |
| 60 | MP0002132_abnormal_respiratory_system | 1.12667032 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.12664447 |
| 62 | MP0002086_abnormal_extraembryonic_tissu | 1.12061605 |
| 63 | MP0003984_embryonic_growth_retardation | 1.10256591 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.08828375 |
| 65 | MP0002723_abnormal_immune_serum | 1.07751261 |
| 66 | MP0002006_tumorigenesis | 1.06282243 |
| 67 | MP0002405_respiratory_system_inflammati | 1.06230672 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.04730299 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.01724662 |
| 70 | MP0005023_abnormal_wound_healing | 1.01645992 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.00213624 |
| 72 | MP0005501_abnormal_skin_physiology | 0.99268044 |
| 73 | MP0000627_abnormal_mammary_gland | 0.98355614 |
| 74 | MP0000358_abnormal_cell_content/ | 0.96519632 |
| 75 | MP0003186_abnormal_redox_activity | 0.96339538 |
| 76 | MP0005025_abnormal_response_to | 0.95807617 |
| 77 | MP0009785_altered_susceptibility_to | 0.95675610 |
| 78 | MP0003866_abnormal_defecation | 0.95062046 |
| 79 | MP0003943_abnormal_hepatobiliary_system | 0.94313185 |
| 80 | MP0010155_abnormal_intestine_physiology | 0.93777775 |
| 81 | MP0003436_decreased_susceptibility_to | 0.93702540 |
| 82 | MP0004381_abnormal_hair_follicle | 0.92882056 |
| 83 | MP0003315_abnormal_perineum_morphology | 0.92763375 |
| 84 | MP0004133_heterotaxia | 0.92409195 |
| 85 | MP0002938_white_spotting | 0.92094665 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.91922344 |
| 87 | MP0001293_anophthalmia | 0.91504862 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.90847086 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.90302799 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.90288011 |
| 91 | MP0010030_abnormal_orbit_morphology | 0.88863425 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 0.87951572 |
| 93 | MP0008995_early_reproductive_senescence | 0.87702530 |
| 94 | MP0001764_abnormal_homeostasis | 0.86911313 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 0.86237836 |
| 96 | MP0009278_abnormal_bone_marrow | 0.84611938 |
| 97 | MP0003718_maternal_effect | 0.84370195 |
| 98 | MP0003121_genomic_imprinting | 0.81981219 |
| 99 | MP0000477_abnormal_intestine_morphology | 0.79992309 |
| 100 | MP0001873_stomach_inflammation | 0.79551509 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 0.79480037 |
| 102 | MP0001790_abnormal_immune_system | 0.78701389 |
| 103 | MP0005387_immune_system_phenotype | 0.78701389 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.77191122 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.76202719 |
| 106 | MP0002009_preneoplasia | 0.76132916 |
| 107 | MP0004947_skin_inflammation | 0.74649177 |
| 108 | MP0003941_abnormal_skin_development | 0.73102879 |
| 109 | MP0008260_abnormal_autophagy | 0.70755807 |
| 110 | MP0003448_altered_tumor_morphology | 0.68778208 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.68635564 |
| 112 | MP0002796_impaired_skin_barrier | 0.68164192 |
| 113 | MP0000681_abnormal_thyroid_gland | 0.67710286 |
| 114 | MP0005384_cellular_phenotype | 0.67502867 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 0.67293279 |
| 116 | MP0002210_abnormal_sex_determination | 0.67127908 |
| 117 | MP0002163_abnormal_gland_morphology | 0.67100664 |
| 118 | MP0002111_abnormal_tail_morphology | 0.66393703 |
| 119 | MP0000609_abnormal_liver_physiology | 0.66216362 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.65924909 |
| 121 | MP0001216_abnormal_epidermal_layer | 0.65379033 |
| 122 | MP0005408_hypopigmentation | 0.65020150 |
| 123 | MP0008877_abnormal_DNA_methylation | 0.62793391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 8.54010501 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 7.46546743 |
| 3 | Reticulocytopenia (HP:0001896) | 7.41796338 |
| 4 | Macrocytic anemia (HP:0001972) | 5.44821970 |
| 5 | Pallor (HP:0000980) | 5.14142837 |
| 6 | Acute encephalopathy (HP:0006846) | 4.17514217 |
| 7 | Colon cancer (HP:0003003) | 3.90203577 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.79684243 |
| 9 | Thrombocytosis (HP:0001894) | 3.71689541 |
| 10 | Cerebral edema (HP:0002181) | 3.58683462 |
| 11 | Microvesicular hepatic steatosis (HP:0001414) | 3.38703556 |
| 12 | Increased intramyocellular lipid droplets (HP:0012240) | 3.34458230 |
| 13 | 11 pairs of ribs (HP:0000878) | 3.32201522 |
| 14 | Aplastic anemia (HP:0001915) | 3.30761159 |
| 15 | Birth length less than 3rd percentile (HP:0003561) | 3.15733390 |
| 16 | Oral leukoplakia (HP:0002745) | 3.02512434 |
| 17 | Absent thumb (HP:0009777) | 2.97279760 |
| 18 | Selective tooth agenesis (HP:0001592) | 2.97142394 |
| 19 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.93895770 |
| 20 | Increased muscle lipid content (HP:0009058) | 2.91369364 |
| 21 | IgM deficiency (HP:0002850) | 2.86252166 |
| 22 | Multiple enchondromatosis (HP:0005701) | 2.80156575 |
| 23 | Trismus (HP:0000211) | 2.78778145 |
| 24 | Stenosis of the external auditory canal (HP:0000402) | 2.75889448 |
| 25 | Exercise intolerance (HP:0003546) | 2.71784310 |
| 26 | Breast hypoplasia (HP:0003187) | 2.69709891 |
| 27 | Rough bone trabeculation (HP:0100670) | 2.61211957 |
| 28 | Abnormality of reticulocytes (HP:0004312) | 2.60319715 |
| 29 | Renal Fanconi syndrome (HP:0001994) | 2.58298417 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 2.58293846 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 2.52377703 |
| 32 | Progressive muscle weakness (HP:0003323) | 2.48464320 |
| 33 | Seborrheic dermatitis (HP:0001051) | 2.48020062 |
| 34 | Microretrognathia (HP:0000308) | 2.46012338 |
| 35 | Leukodystrophy (HP:0002415) | 2.44435860 |
| 36 | Carpal bone hypoplasia (HP:0001498) | 2.42315730 |
| 37 | Abnormal hemoglobin (HP:0011902) | 2.41790252 |
| 38 | Asplenia (HP:0001746) | 2.40640066 |
| 39 | B lymphocytopenia (HP:0010976) | 2.39256489 |
| 40 | Lactic acidosis (HP:0003128) | 2.37922052 |
| 41 | Depressed nasal ridge (HP:0000457) | 2.32035822 |
| 42 | Missing ribs (HP:0000921) | 2.29020777 |
| 43 | Basal cell carcinoma (HP:0002671) | 2.28709799 |
| 44 | Glossoptosis (HP:0000162) | 2.28687659 |
| 45 | Neoplasm of the pancreas (HP:0002894) | 2.25510905 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.25087004 |
| 47 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.25087004 |
| 48 | Increased serum lactate (HP:0002151) | 2.24911225 |
| 49 | Premature graying of hair (HP:0002216) | 2.24543291 |
| 50 | Myelodysplasia (HP:0002863) | 2.22699382 |
| 51 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.20408283 |
| 52 | Respiratory failure (HP:0002878) | 2.18737721 |
| 53 | Increased hepatocellular lipid droplets (HP:0006565) | 2.16489436 |
| 54 | Agnosia (HP:0010524) | 2.15651304 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.15064911 |
| 56 | Patellar aplasia (HP:0006443) | 2.14499244 |
| 57 | Hepatic necrosis (HP:0002605) | 2.09496264 |
| 58 | Degeneration of anterior horn cells (HP:0002398) | 2.08864635 |
| 59 | Abnormality of the anterior horn cell (HP:0006802) | 2.08864635 |
| 60 | Abnormal number of incisors (HP:0011064) | 2.07686373 |
| 61 | Lymphoma (HP:0002665) | 2.07322327 |
| 62 | Cellular immunodeficiency (HP:0005374) | 2.05515641 |
| 63 | Acute lymphatic leukemia (HP:0006721) | 2.03441670 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02855777 |
| 65 | Thick lower lip vermilion (HP:0000179) | 2.02417647 |
| 66 | Exertional dyspnea (HP:0002875) | 2.02126843 |
| 67 | Hyperthyroidism (HP:0000836) | 2.01752971 |
| 68 | Gastrointestinal stroma tumor (HP:0100723) | 2.01249367 |
| 69 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.00801028 |
| 70 | Ependymoma (HP:0002888) | 2.00788668 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.00722316 |
| 72 | Acute necrotizing encephalopathy (HP:0006965) | 2.00403855 |
| 73 | Atresia of the external auditory canal (HP:0000413) | 1.97501948 |
| 74 | Amaurosis fugax (HP:0100576) | 1.97039541 |
| 75 | Mitochondrial inheritance (HP:0001427) | 1.93921792 |
| 76 | Cleft eyelid (HP:0000625) | 1.93279804 |
| 77 | Cerebral hypomyelination (HP:0006808) | 1.93243318 |
| 78 | Hypoplasia of the radius (HP:0002984) | 1.92910188 |
| 79 | Abnormality of glycolysis (HP:0004366) | 1.92558027 |
| 80 | Ragged-red muscle fibers (HP:0003200) | 1.92091903 |
| 81 | Hypertensive crisis (HP:0100735) | 1.91722422 |
| 82 | Abnormality of methionine metabolism (HP:0010901) | 1.90216835 |
| 83 | Abnormality of B cell number (HP:0010975) | 1.89486976 |
| 84 | Chronic otitis media (HP:0000389) | 1.89431129 |
| 85 | Abnormality of the thymus (HP:0000777) | 1.88033231 |
| 86 | Migraine (HP:0002076) | 1.87717288 |
| 87 | Congenital, generalized hypertrichosis (HP:0004540) | 1.86732239 |
| 88 | Squamous cell carcinoma (HP:0002860) | 1.85864789 |
| 89 | Esophageal neoplasm (HP:0100751) | 1.85193532 |
| 90 | Neoplasm of head and neck (HP:0012288) | 1.85193532 |
| 91 | Triphalangeal thumb (HP:0001199) | 1.85000669 |
| 92 | Abnormality of the preputium (HP:0100587) | 1.84031390 |
| 93 | Abnormal trabecular bone morphology (HP:0100671) | 1.83902227 |
| 94 | Respiratory difficulties (HP:0002880) | 1.83322637 |
| 95 | Obstructive lung disease (HP:0006536) | 1.82340317 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82340317 |
| 97 | Petechiae (HP:0000967) | 1.82277407 |
| 98 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82045529 |
| 99 | Increased serum pyruvate (HP:0003542) | 1.81744001 |
| 100 | Medulloblastoma (HP:0002885) | 1.81579915 |
| 101 | Villous atrophy (HP:0011473) | 1.81522098 |
| 102 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.81522098 |
| 103 | Recurrent bronchitis (HP:0002837) | 1.79153049 |
| 104 | Abnormality of T cells (HP:0002843) | 1.78577276 |
| 105 | Lipid accumulation in hepatocytes (HP:0006561) | 1.78269025 |
| 106 | Colitis (HP:0002583) | 1.76418347 |
| 107 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.76343415 |
| 108 | Horseshoe kidney (HP:0000085) | 1.75101623 |
| 109 | Optic disc pallor (HP:0000543) | 1.74869261 |
| 110 | Proximal placement of thumb (HP:0009623) | 1.74802262 |
| 111 | Hepatocellular necrosis (HP:0001404) | 1.73791131 |
| 112 | Bone marrow hypocellularity (HP:0005528) | 1.73584387 |
| 113 | Glioma (HP:0009733) | 1.73563059 |
| 114 | Premature ovarian failure (HP:0008209) | 1.73510462 |
| 115 | Increased CSF lactate (HP:0002490) | 1.73292179 |
| 116 | Poikiloderma (HP:0001029) | 1.73227374 |
| 117 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.72401310 |
| 118 | Progressive external ophthalmoplegia (HP:0000590) | 1.72221044 |
| 119 | Abnormal protein glycosylation (HP:0012346) | 1.71149506 |
| 120 | Abnormal glycosylation (HP:0012345) | 1.71149506 |
| 121 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.71149506 |
| 122 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.71149506 |
| 123 | Tracheoesophageal fistula (HP:0002575) | 1.71005164 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 1.70295930 |
| 125 | Hyperacusis (HP:0010780) | 1.67952700 |
| 126 | Lethargy (HP:0001254) | 1.67632704 |
| 127 | Deviation of the thumb (HP:0009603) | 1.67067788 |
| 128 | Pancytopenia (HP:0001876) | 1.66094601 |
| 129 | IgG deficiency (HP:0004315) | 1.65557478 |
| 130 | Hypoparathyroidism (HP:0000829) | 1.65456925 |
| 131 | Meckel diverticulum (HP:0002245) | 1.64533827 |
| 132 | Sparse eyelashes (HP:0000653) | 1.64331096 |
| 133 | Recurrent viral infections (HP:0004429) | 1.63887481 |
| 134 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.63860911 |
| 135 | Absent radius (HP:0003974) | 1.63577254 |
| 136 | Secondary amenorrhea (HP:0000869) | 1.63066209 |
| 137 | Panhypogammaglobulinemia (HP:0003139) | 1.62338324 |
| 138 | Optic nerve coloboma (HP:0000588) | 1.61016197 |
| 139 | Abnormality of the ileum (HP:0001549) | 1.60627815 |
| 140 | Neoplasm of the colon (HP:0100273) | 1.59990329 |
| 141 | Type I transferrin isoform profile (HP:0003642) | 1.59838866 |
| 142 | Irregular epiphyses (HP:0010582) | 1.58199889 |
| 143 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.58007432 |
| 144 | T lymphocytopenia (HP:0005403) | 1.57516806 |
| 145 | Truncus arteriosus (HP:0001660) | 1.57084208 |
| 146 | Abnormality of DNA repair (HP:0003254) | 1.56957242 |
| 147 | Thoracic kyphosis (HP:0002942) | 1.56874205 |
| 148 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.56403500 |
| 149 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.55937688 |
| 150 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.55388796 |
| 151 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.55388796 |
| 152 | Single umbilical artery (HP:0001195) | 1.55388796 |
| 153 | Abnormality of chromosome stability (HP:0003220) | 1.53746380 |
| 154 | Bicuspid aortic valve (HP:0001647) | 1.53535152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.72970564 |
| 2 | BUB1 | 3.68988271 |
| 3 | WEE1 | 3.47788616 |
| 4 | VRK2 | 3.14673578 |
| 5 | SMG1 | 2.94670971 |
| 6 | EEF2K | 2.75885995 |
| 7 | RPS6KB2 | 2.67943579 |
| 8 | CDC7 | 2.54699859 |
| 9 | MATK | 2.44272535 |
| 10 | PASK | 2.36990002 |
| 11 | LRRK2 | 2.34301741 |
| 12 | TGFBR1 | 2.16159891 |
| 13 | MAP4K1 | 2.15891835 |
| 14 | PRPF4B | 2.04680554 |
| 15 | EIF2AK1 | 1.97494835 |
| 16 | SRPK1 | 1.95612717 |
| 17 | NEK2 | 1.87139800 |
| 18 | TSSK6 | 1.80697216 |
| 19 | PIM2 | 1.79308632 |
| 20 | VRK1 | 1.78350456 |
| 21 | TESK2 | 1.71032420 |
| 22 | STK16 | 1.70460414 |
| 23 | DYRK3 | 1.66695069 |
| 24 | MST4 | 1.64603482 |
| 25 | EPHA2 | 1.61907864 |
| 26 | RPS6KA4 | 1.61516755 |
| 27 | EIF2AK3 | 1.60724836 |
| 28 | SCYL2 | 1.50968145 |
| 29 | MAP3K10 | 1.48888193 |
| 30 | AURKB | 1.48167891 |
| 31 | STK10 | 1.44047250 |
| 32 | BRSK2 | 1.41179331 |
| 33 | ACVR1B | 1.40818288 |
| 34 | TLK1 | 1.39787380 |
| 35 | FLT3 | 1.38545881 |
| 36 | CDK7 | 1.37931994 |
| 37 | PAK4 | 1.32082506 |
| 38 | PKN2 | 1.31670342 |
| 39 | RIPK4 | 1.30370965 |
| 40 | MAP3K8 | 1.28269609 |
| 41 | PLK1 | 1.24607988 |
| 42 | ICK | 1.20743610 |
| 43 | TAF1 | 1.20279338 |
| 44 | TTK | 1.19056654 |
| 45 | ATR | 1.18873724 |
| 46 | MAPKAPK3 | 1.14163119 |
| 47 | PIM1 | 1.14086849 |
| 48 | KDR | 1.13633514 |
| 49 | MKNK1 | 1.11002340 |
| 50 | ILK | 1.10650241 |
| 51 | ZAP70 | 1.09922934 |
| 52 | GRK6 | 1.09848596 |
| 53 | PLK4 | 1.08868850 |
| 54 | CDK4 | 1.07928494 |
| 55 | BTK | 1.07441290 |
| 56 | ARAF | 1.06376655 |
| 57 | NME1 | 0.95054471 |
| 58 | NEK1 | 0.94404906 |
| 59 | MAP2K3 | 0.93892513 |
| 60 | AURKA | 0.93229438 |
| 61 | STK4 | 0.91980671 |
| 62 | BCKDK | 0.83256748 |
| 63 | ERN1 | 0.83224932 |
| 64 | TYK2 | 0.81186050 |
| 65 | TESK1 | 0.78454204 |
| 66 | CSNK2A2 | 0.78246310 |
| 67 | JAK3 | 0.77632844 |
| 68 | IRAK3 | 0.77426158 |
| 69 | RPS6KA5 | 0.76909473 |
| 70 | MAP3K3 | 0.76161142 |
| 71 | PLK3 | 0.75803423 |
| 72 | FGFR4 | 0.75789359 |
| 73 | BLK | 0.74131952 |
| 74 | * CHEK1 | 0.71268785 |
| 75 | CHEK2 | 0.71076922 |
| 76 | IKBKB | 0.71013905 |
| 77 | TEC | 0.69943907 |
| 78 | SIK1 | 0.67641754 |
| 79 | PAK1 | 0.67252145 |
| 80 | BRSK1 | 0.65730021 |
| 81 | BRAF | 0.65533829 |
| 82 | MST1R | 0.64683361 |
| 83 | KIT | 0.64067959 |
| 84 | MAP3K11 | 0.63422029 |
| 85 | CSNK2A1 | 0.60777167 |
| 86 | PDK2 | 0.60177298 |
| 87 | PRKCI | 0.59605192 |
| 88 | SYK | 0.55875313 |
| 89 | CDK12 | 0.54995345 |
| 90 | CDK19 | 0.54737462 |
| 91 | ABL2 | 0.53118882 |
| 92 | CSF1R | 0.52778848 |
| 93 | CDK6 | 0.52064011 |
| 94 | IRAK4 | 0.51246395 |
| 95 | CDK2 | 0.50025339 |
| 96 | PAK2 | 0.49826989 |
| 97 | LCK | 0.48553470 |
| 98 | ITK | 0.48467369 |
| 99 | MAP2K2 | 0.48080305 |
| 100 | TRIB3 | 0.47307429 |
| 101 | ATM | 0.47258387 |
| 102 | CDK8 | 0.46935554 |
| 103 | ZAK | 0.46815439 |
| 104 | ALK | 0.45342298 |
| 105 | MAP3K13 | 0.44853611 |
| 106 | TAOK2 | 0.44793822 |
| 107 | NLK | 0.43186220 |
| 108 | TBK1 | 0.41407013 |
| 109 | LYN | 0.40306361 |
| 110 | BRD4 | 0.39550596 |
| 111 | MARK3 | 0.38502842 |
| 112 | PBK | 0.38330774 |
| 113 | TXK | 0.37653471 |
| 114 | LIMK1 | 0.36152002 |
| 115 | MAPKAPK2 | 0.35265391 |
| 116 | CDK1 | 0.34639383 |
| 117 | MAPK11 | 0.34226001 |
| 118 | MAP3K14 | 0.34058280 |
| 119 | MTOR | 0.33494389 |
| 120 | RPS6KA6 | 0.33408589 |
| 121 | AKT2 | 0.32968793 |
| 122 | CLK1 | 0.32890102 |
| 123 | HIPK2 | 0.32317131 |
| 124 | RPS6KL1 | 0.32274463 |
| 125 | RPS6KC1 | 0.32274463 |
| 126 | MELK | 0.28752670 |
| 127 | DAPK3 | 0.27854641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Ribosome_Homo sapiens_hsa03010 | 6.57755607 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.00505676 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.69803270 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.43269568 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.23776958 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 3.13699493 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.94032061 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.57267952 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.46692410 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.45121437 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.35417241 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.31140230 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.04244446 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.94355476 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 1.84835273 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.75560360 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60329822 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.57361710 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.55615946 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.46439499 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44967079 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.42450404 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.41281385 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.39839123 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.37645033 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.35785414 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31293443 |
| 28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24532055 |
| 29 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.22266623 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20038478 |
| 31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.16290944 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.08947435 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95972466 |
| 34 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94113877 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93484878 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92422343 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88587951 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84712911 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79421274 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77856225 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76355724 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75629993 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74658049 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74511444 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.70765039 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69212757 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67058975 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.65993579 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65728113 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65485061 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64181387 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63007727 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62306048 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.60266066 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.59978959 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59094745 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56450259 |
| 58 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.55374261 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51429785 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49054190 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48222409 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.48115046 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48059377 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45779775 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45313686 |
| 66 | Alcoholism_Homo sapiens_hsa05034 | 0.44860314 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44714078 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44682197 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44441269 |
| 70 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42645512 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41398317 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.41340626 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41322289 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40501734 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39951706 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39841855 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39027572 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38886929 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37738728 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37717406 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37652369 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37456970 |
| 83 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36970213 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36851268 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.36204793 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35360825 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34970603 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34530112 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.34069293 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33997673 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33198486 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33128403 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32169899 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31661739 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30783280 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30477721 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30337994 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30169387 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29372073 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.29335415 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.28879050 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27952835 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.26774483 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26666960 |
| 105 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26427255 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.26062561 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.25907268 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.25459928 |
| 109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25001046 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.21368672 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.19708941 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19525011 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19457393 |
| 114 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.18316030 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18057814 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17979728 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.17813143 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.17165564 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15935951 |
| 120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14658009 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14276056 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.13603291 |

